For the third year in a row, Cleveland Diagnostics is commemorating September’s Prostate Cancer Awareness Month with its “A PSA on PSA” campaign, which serves as a public service announcement about ...

Fear of discomfort and unnecessary treatment often deters patients from prostate cancer screening, despite the benefits of early detection. Prostate cancer can be asymptomatic, making early detection ...

Opportunistic prostate cancer screening can lead to overdiagnosis of indolent diseases and invasive procedures. A cohort study suggested that a low baseline PSA level in midlife was associated with a ...

Prostate-cancer screening based on prostate-specific antigen (PSA) levels in the blood was introduced—and readily adopted—in the United States around the late 1980s. But this screening method, in ...

Editor's note: second of two parts; read part one here. In the first part of our series, we described how PSA is used as a screening tool to help detect prostate cancer in men who don't have symptoms.

Just when society is beginning to get to grips with one of the main killers of men in the UK, prostate cancer, along comes an ...

The prostate health index (PHI) is a blood test that more accurately assesses the risk of prostate cancer than a traditional PSA test. The PHI combines three different PSA tests to create one risk ...

Source: Getty Images Investigators analyzed exfoliated cells in urine specimens to identify 50 candidate RNAs for prostate cancer detection. Serum PSA testing is not specific to prostate cancer, and ...

Researchers identified three biomarkers that robustly detected the presence of prostate cancer Prostate biopsies after abnormal PSA blood test results are often negative and can result in unintended ...

Sir Chris Hoy reveals prostate cancer diagnosis gave him ‘new purpose’ as he launches mass screening drive - The Olympian ...

A landmark UK trial aiming to revolutionise prostate cancer screening has begun testing its first male participants. The ...

A low baseline prostate-specific antigen (PSA) level in midlife was associated with a reduced long-term risk of prostate cancer, according to a German cohort study. Among the 1,482 men with serum PSA ...